Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
About Investor
Tom Willis is currently Venture Partner at Illumina Ventures and as of June 2025 also serves as CEO of Arima Genomics, the company leveraging whole-genome structure for advances in cancer diagnostics. He invests within biotech and diagnostics, across Seed to Series A stages, with a range of $100 K to $5 M. He brings over two decades of genomics entrepreneurship—founding and exiting ParAllele BioScience and Sequenta—and earlier directed technology development at Stanford Genome Technology Center during the Human Genome Project.
Previous investments
SonoThera
61M |2022
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.